Alopecia World
www.alopeciaworld.com
An Open-Label Subpopulation Study to Evaluate Efficacy and Safety of Baricitinib in Participants that Identify as Black or African American
CLINICAL TRIAL:
An ongoing clinical research study is currently recruiting Black and African American patients with alopecia areata for a study that evaluates the safety and effectiveness of an oral drug. Would you like to know more about this study? This study is testing a drug called baricitinib (the “study drug”) in people with alopecia areata. The purpose of the study is to learn how the study drug can help patients, particularly Black and African American patients with alopecia areata regrow their hair .You may qualify to participate in this study if you are 18 to 60 years for males (70 years of age for females), self identify as Black or African American in race, have at least 50% scalp hair loss, and have been diagnosed with alopecia areata for at least 6 months.
This study will occur at multiple clinical trial sites throughout the United States. Click here to learn more:
https://www.naaf.org/studies/an-open-label-subpopulation-study-to-e....
To read posts and experiences from member on Alopecia World about baricitinib, click below.
-
Comment by Karen Grevious on June 9, 2023 at 2:21am
-
Before you even think of participating in this read Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present. This sounds like another biologic, which can increase your risk of certain cancers and make you more susceptible to opportunistic infections.
Comment
© 2024 Created by Alopecia World.
Powered by
You need to be a member of Alopecia World to add comments!
Join Alopecia World